Healwell AI Inc.
AIDX.TOTSXHealthcare● Active
$0.88
+$0.01(+1.15%)
Market Cap$260091919
P/E Ratio—
52W High$1.635
52W Low$0.58
Healwell AI Inc. (AIDX.TO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AIDX.TO · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.02
Est. -$0.02 · -7.7%
Revenue
$0.03B
Est. $0.03B · +5.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
AIDX.TO reports quarterly as a TSX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | -$0.02 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.02 | -$0.02 | -7.7% | $0.03B | $0.03B | +5.1% |
| ▲ Q1 FY2026 | Mar 19, 2026 | -$0.03 | -$0.02 | +39.1% | $0.03B | $0.03B | +4.2% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.02 | -$0.12 | -485.8% | $0.03B | $0.03B | -2.6% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.01 | -$0.02 | -58.0% | $0.04B | $0.04B | +4.3% |
| ▼ Q2 FY2025 | May 12, 2025 | -$0.04 | -$0.22 | -450.0% | $0.01B | $0.01B | +8.3% |
| ▼ Q1 FY2025 | Mar 26, 2025 | -$0.04 | -$0.10 | -169.9% | $0.02B | $0.01B | +5.8% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.04 | -$0.06 | -33.3% | $0.01B | $0.01B | -4.4% |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
-7.7%
Revenue
$0.03B
Q1 FY2026
Mar 19, 2026Beat
EPS Actual
-$0.02
EPS Est.
-$0.03
EPS Surpr.
+39.1%
Revenue
$0.03B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.12
EPS Est.
-$0.02
EPS Surpr.
-485.8%
Revenue
$0.03B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-58.0%
Revenue
$0.04B
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.22
EPS Est.
-$0.04
EPS Surpr.
-450.0%
Revenue
$0.01B
Q1 FY2025
Mar 26, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.04
EPS Surpr.
-169.9%
Revenue
$0.02B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.06
EPS Est.
-$0.04
EPS Surpr.
-33.3%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.01 | $-0.01 | $-0.00 | 1 |
| Q3 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q3 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -7.7% | $0.97 | $0.95 | -2.06% |
| ▲ Q1 FY2026 | Mar 19, 2026 | +39.1% | $0.93 | $0.90 | -3.23% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -485.8% | $1.37 | $1.34 | -2.19% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -58.0% | $1.40 | $1.54 | +10.00% |
| ▼ Q2 FY2025 | May 12, 2025 | -450.0% | $1.46 | $1.51 | +3.42% |
| ▼ Q1 FY2025 | Mar 26, 2025 | -169.9% | $1.60 | $1.63 | +1.87% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -33.3% | $1.77 | $1.81 | +2.26% |
| ▲ Q3 FY2024 | Aug 12, 2024 | +160.1% | $1.93 | $2.06 | +6.74% |
Q2 FY2026-2.06%
Report Date
May 7, 2026
EPS Beat/Miss
-7.7%
Price Before
$0.97
Price After
$0.95
Q1 FY2026-3.23%
Report Date
Mar 19, 2026
EPS Beat/Miss
+39.1%
Price Before
$0.93
Price After
$0.90
Q4 FY2025-2.19%
Report Date
Nov 6, 2025
EPS Beat/Miss
-485.8%
Price Before
$1.37
Price After
$1.34
Q3 FY2025+10.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
-58.0%
Price Before
$1.40
Price After
$1.54
Q2 FY2025+3.42%
Report Date
May 12, 2025
EPS Beat/Miss
-450.0%
Price Before
$1.46
Price After
$1.51
Q1 FY2025+1.87%
Report Date
Mar 26, 2025
EPS Beat/Miss
-169.9%
Price Before
$1.60
Price After
$1.63
Q4 FY2024+2.26%
Report Date
Nov 12, 2024
EPS Beat/Miss
-33.3%
Price Before
$1.77
Price After
$1.81
Q3 FY2024+6.74%
Report Date
Aug 12, 2024
EPS Beat/Miss
+160.1%
Price Before
$1.93
Price After
$2.06
Avg Beat Reaction+1.76%
Avg Miss Reaction+2.22%
Beat Rate2 / 8 quarters
Largest Move+10.00% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AIDX.TO ends December
Healwell AI Inc. (AIDX.TO) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.02 — missing the analyst consensus of $-0.02 by -7.7%. The next AIDX.TO earnings date is expected around September 1, 2026.
Each quarter, investors track AIDX.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AIDX.TO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AIDX.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AIDX.TO earnings · 5 questionsHealwell AI Inc.'s next earnings report is expected around September 1, 2026. AIDX.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AIDX.TO historically reports after market close (AMC).
AIDX.TO earnings datewhen is AIDX.TO earningsAIDX.TO next earnings datewhen does AIDX.TO report earningsAIDX.TO earnings calendar
▸ Source: FMP · Healwell AI Inc. SEC filings · US GAAP · Healwell AI Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026